Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pan Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04645160
What this trial is testing

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)UnknownNCT04004234
What this trial is testing

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Who this might be right for
Biliary Tract Cancer (BTC)
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Testing effectiveness (Phase 2)WithdrawnNCT05041972
What this trial is testing

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Who this might be right for
HER2 Mutation-Related TumorsHER2 Amplified Solid Tumors
Ambrx, Inc.
Early research (Phase 1)Looking for participantsNCT06326411
What this trial is testing

Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Who this might be right for
OncologyMEK MutationRAF Gene Mutation+6 more
Nested Therapeutics, Inc 230
Early research (Phase 1)UnknownNCT06078800
What this trial is testing

YL-17231 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 80
Not applicableStudy completedNCT02594436
What this trial is testing

The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

Who this might be right for
Actinic Keratosis
LEO Pharma 440
Testing effectiveness (Phase 2)Looking for participantsNCT06003621
What this trial is testing

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Who this might be right for
Solid Tumor, Adult
Omico 96
Not applicableActive Not RecruitingNCT07584044
What this trial is testing

A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor Therapy

Who this might be right for
Tumor MicroenvironmentAntibody
Tianjin Medical University Cancer Institute and Hospital 300
Early research (Phase 1)Ended earlyNCT00933985
What this trial is testing

Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT01570296
What this trial is testing

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Who this might be right for
Non-Small Cell Lung CancerSolid Tumors
National Cancer Centre, Singapore 38
Not applicableStudy completedNCT00299195
What this trial is testing

Study of Sulindac in Oral Premalignant Lesions

Who this might be right for
Leukoplakia, OralBenign Neoplasms
Memorial Sloan Kettering Cancer Center 63
Not applicableStudy completedNCT04972201
What this trial is testing

A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy

Who this might be right for
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,305
Early research (Phase 1)Ended earlyNCT01071564
What this trial is testing

RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+5 more
National Cancer Institute (NCI) 13
Not applicableWithdrawnNCT01888562
What this trial is testing

Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma

Who this might be right for
Endometrial Neoplasms
Washington University School of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT06439888
What this trial is testing

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Who this might be right for
Oligometastatic DiseaseSolid Tumor, Adult
Gustave Roussy, Cancer Campus, Grand Paris 58
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660654
What this trial is testing

Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumors
Daiichi Sankyo 200
Early research (Phase 1)Ended earlyNCT03355066
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Biosplice Therapeutics, Inc. 82
Not applicableActive Not RecruitingNCT03421132
What this trial is testing

Multiple Myeloma Molecular Monitoring Study

Who this might be right for
Multiple Myeloma
Horizon Health Network 96
Next Page